4
Changes in Ownership
ALX ONCOLOGY HOLDINGS INC Filed Acc 0001209191-21-053218
Chief Financial Officer sold 60,000 shares at an average $74.15 ($4,448,762)
- Chief Financial Officer acquired 60,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
GARCIA PETER S · Chief Financial Officer
Table I: Non-derivative
9 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-08-23 | Exercise or conversion : show line 1 in the form | +60,000 | $4.08 | $244,800 | 69,331 | D |
| 2021-08-23 | Sale : show line 2 in the form | −1,593 | $70.86 | $112,872 | 67,738 | D |
| 2021-08-23 | Sale : show line 3 in the form | −3,497 | $72.03 | $251,906 | 64,241 | D |
| 2021-08-23 | Sale : show line 4 in the form | −18,060 | $72.66 | $1,312,252 | 46,181 | D |
| 2021-08-23 | Sale : show line 5 in the form | −4,008 | $73.57 | $294,871 | 42,173 | D |
| 2021-08-23 | Sale : show line 6 in the form | −19,448 | $75.09 | $1,460,278 | 22,725 | D |
| 2021-08-23 | Sale : show line 7 in the form | −10,743 | $75.71 | $813,317 | 11,982 | D |
| 2021-08-23 | Sale : show line 8 in the form | −2,616 | $76.66 | $200,550 | 9,366 | D |
| 2021-08-23 | Sale : show line 9 in the form | −35 | $77.56 | $2,715 | 9,331 | D |
| Open-market sales · 60,000 sh · avg $74.15 · $4,448,762 | ||||||
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2021-08-23 | Exercise or conversion : show line 10 in the form Employee Stock Option (right to buy) | −40,630 | 95,659 | D |
| 2021-08-23 | Exercise or conversion : show line 11 in the form Employee Stock Option (right to buy) | −19,370 | 80,468 | D |
Loading xslF345X03/doc4.xml…